iBrandox Online
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

iBrandox Online

View Profile

Base

Bio

iBrandox, the best website designing company in Delhi, is renowned for its excellence in creating impactful and visually captivating websites. With a strong focus on understanding client requirements, iBrandox delivers tailored solutions that perfectly align with their business goals. Backed by a team of highly skilled professionals and a proven track record of successful projects, iBrandox has earned its reputation as the best website development company in Delhi. If you’re looking for a partner to elevate your online presence and create a remarkable website, iBrandox is your go-to choice. We provide also website redesigning services.
Display Name

iBrandox Online
I am

the patient's relative
Initial Diagnosis Month

January
Initial Diagnosis Year

2021
Stage at Diagnosis

Stage 1
Current Stage

Stage 1
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics